OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
January 29, 2009
Also, UCB will divest certain business in emerging markets to GSK; the KineMatik Group named Michael G. Jarjour president and CEO; more...
January 22, 2009
Also, Elan explores strategic alternatives; NanoGuardian appoints John D. Glover to lead its Security Advisory Board; more...
The US Food and Drug Administration issued its Draft Guidance for Industry on Submission of Laboratory Packages by Accredited Laboratories.
January 21, 2009
An integrated information technology environment can help pharmaceutical companies find new processes and approaches to improve manufacturing efficiency, productivity, and quality.
January 15, 2009
Also, Bristol-Myers Squibb forms collaboration with ZymoGenetics, Hana Biosciences appoints VP of regulatory affairs, more...
January 08, 2009
Also, Novozymes Biologicals settles pollution case with the US Department of Justice; EntreMed restructures management team; more...
January 07, 2009
Outsourcing sterile manufacturing involves an integrated approach in product life-cycle management.
January 02, 2009
Although its domestic market is on the rise, Pakistan's market conditions have not proved welcoming enough to keep foreign investors.
The financial crisis could lead to consolidation in the contract services industry.
The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.